Pfizer

Stock market information for Pfizer Inc. (PFE)

• Pfizer Inc. is a equity in the USA market.
• The price is 24.58 USD currently with a change of 0.35 USD (0.01%) from the previous close.
• The latest open price was 24.22 USD and the intraday volume is 36,376,966.
• The intraday high is 24.61 USD and the intraday low is 24.17 USD.
• The latest trade time is Friday, August 8, 23:59:46 UTC.

Pfizer Inc. is a leading global biopharmaceutical company dedicated to advancing wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

With a rich history spanning over 170 years, Pfizer has been at the forefront of medical innovation, striving to make a difference for all who rely on its products and services.

Product Portfolio

Pfizer's diverse portfolio encompasses a wide range of medicines and vaccines across therapeutic areas including immunology, oncology, cardiology, endocrinology, and neurology.

Key products include:

• Eliquis (apixaban): A blood thinner to reduce stroke and blood clot risk.
• Prevnar: A vaccine to prevent pneumococcal diseases.
• Paxlovid: An antiviral treatment for COVID-19.
• Vyndaqel: Treatment for transthyretin amyloid cardiomyopathy.
• Comirnaty: Pfizer-BioNTech COVID-19 vaccine.
• Ibrance: Used in treating certain breast cancers.

In 2024, these products generated significant revenue:

• Eliquis: $7.3 billion
• Prevnar: $6.4 billion
• Paxlovid: $5.7 billion
• Vyndaqel: $5.4 billion
• Comirnaty: $5.3 billion
• Ibrance: $4.3 billion

Global Presence

Pfizer operates in approximately 200 countries and territories worldwide, with manufacturing sites in 37 locations.

The company's global headquarters are located at 66 Hudson Yards, New York, NY, USA.

Recent Developments

In 2023, Pfizer received approval for its vaccine targeting respiratory syncytial virus (RSV), an important respiratory illness affecting infants and older adults.

This highlights Pfizer's commitment to infectious diseases and expanding its vaccine portfolio.

In 2022, Pfizer launched the Accord for a Healthier World program, providing 23 essential medicines and vaccines at cost to 45 low- and middle-income countries.

This initiative aims to reduce health disparities and improve access to critical treatments worldwide, reflecting Pfizer's dedication to global health equity.

Local Operations

In the United States, Pfizer has a manufacturing site in Kenosha, Wisconsin. This is part of its extensive U.S. manufacturing network.

The company's network includes:

• 10 manufacturing sites
• 2 distribution centers

Pfizer's dedication to innovation, global health, and community engagement continues to drive its mission of delivering high-quality healthcare solutions worldwide.